prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumB, IGA-EW-A2FW-01A-PR. Pathologic Interpretation: A. SENTINEL NODE # 1 COUNT. - No malignancy seen in one lymph node (0/1). . Keratin immunostain to follow. B. SUSPICIOUS LYMPH NODE RIGHT BREAST: - No malignancy seen in one lymph node (0/1). - Keratin immunostain to follow. c. SENTINEL NODE # 2 COUNT. - No malignancy seen in one lymph node (0/1). - Keratin immunostaln to follow. D. SENTINEL NODE # 3 COUNT. - No malignancy seen in one lymph node (0/1). - Keratin immunostain to follow. E. SENTINEL NODE #4 COUNT. - No malignancy seen in one lymph node (0/1). - Keratin immunostain to follow. F. SENTINEL NODE # 5 COUNT. - No malignancy seen in one lymph node (0/1). - Keratin immunostain to follow. G. RIGHT BREAST, SHORT STITCH SUPERIOR LONG LATERAL: - Invasive ductal carcinoma, poorly differentiated, Nottingham grade 2 (3 +2+1 = 6), papiliary type, 2.8 cm in greatest. dimension. - Resection margin is free of tumor; closest margin, 1.5 mm. - Lymphovascular invasion is not identified. - Ductal carcinoma in situ, high grade (DIN 3), with necrosis. - Margins are free of DCIS. - See tumor summary. TUMOR SUMMARY: Specimen: - Partial breast. Procedure;. - Other (specify): Partial mastectomy. Lymph Node Sampling: - Sentinel lymph node(s). Specimen Integrity: - Single intact specimen (margins can be evaluated). Specimen Size: - Greatest dimension: 11 cm. . Additional dimension: 10 x 6 cm. Specimen Laterality: - Right. Tumor Site: Invasive Carcinoma. - Upper outer quadrant. - Lower outer quadrant. Tumor Size: Size of Largest Invasive Carcinoma. - Greatest dimension of largest focus of invasion over 0.1 cm: 2.8 cm. Tumor Focality: - Single focus of invasive carcinoma. Macroscopic and Microscopic Extent of tumor: Skin: Invasive carcinoma does not invade into the dermis or epidermis. - Skeletal muscle: No skeletal muscle present. Ductal Carcinoma In Situ (DCIS): - DCIS is present. - Extensive intraductal component (EIC) negative. - Architectural Patterns: Comedo. - Nuclear Grade: Grade III (high). Lobular Carcinoma In Situ. - Not identified. Histologic Type of Invasive Carcinoma: - Invasive papillary carcinoma. Histologic Grade: Nottingham Histologic Score. Glandular (Acinar)/Tubular Differentiation: Score 3: <10% of tumor area forming glandular/tubular structures. Nuclear Pleomorphism: Score 2: Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate. variability in both size and shape. Mitotic Count Score 3. Overall Grade: Grade 3: score of 8. Margins: - Margins uninvolved by invasive carcinoma. -Distance from closest margin: 15 mm. - Margins uninvolved by DCIS. Treatment Effect: Response to Presurgical (Neoadjuvant) therapy: - In the Breast: No known presurgical therapy. - in the Lymph Nodes: No lymph nodes metastases and no prominent fibrous scarring in the nodes. Lymph-Vascular Invasion: Not identified. - Dermal Lymph-Vascular Invasion: Not identified. Lymph Nodes: - Number of sentinel lymph nodes examined: 6. - Total number of lymph nodes examined (sentinel and nonsentinel): 6. - Number of lymph nodes with macrometastases (>0.2 cm): o. Extranodal Extension: Not identified. Method of Evaluation of Sentinel Lymph Nodes: Hematoxylin and eosín (H&E), one level. Immunohistochemistry (PENDING). Pathologic Staging (pTNM): pT2 NO MX. Primary Tumor: pT2: Tumor >20 mm but <50 mm in greatest dimension. Regional Lymph Nodes: (sn): Only sentinel node(s) evaluated. pNO: No regional lymph node metastasis identified histologically. Distant Metastasis: Not applicable. Anciliary Studies: Estrogen Receptor: - Performed on another specimen. Results: Immunoreactive tumor cells present (1%). Progesterone Receptor: - Performed on another specimen. Results: Immunoreactive tumor cells present (1%). Her2: - Performed on another specimen. Results: Negative (Score 0). FISH for HER2/neu: NOT PERFORMED. Microcalcifications: Not identified. NOTE: Some immuno/astochemical antibodies are analyte specific reagents (ASRs) vahdated by our laboratory. These ASRs are chnically useful indicators that do not regare FDA approval. These clones are used: ID5=ER, PgR 636=PR A485=HER2, H-11=ECFR. All stains used with formalis or molecular fixed, paraffn embedded assue. Detection is by Emsion Method. The results any read by a. pathologist as positive or negative. As the attending pathologist, 1 attest that 1: (i) Examined the relevant preparation(s). for the specimen(s); and (ii) Rendered the diagnosis(es). Procedures/Addenda. Addendum. Date Complete: Addendum Diagnosis. A. SENTINEL NODE #1 COUNT. - Keratin is negative by Immunohistochemistry. B. SUSPICIOUS LYMPH NODE RIGHT BREAST: - Keratin is negative by Immunohistochemistry. C. SENTINEL NODE #2 COUNT. - Keratin is negative by Immunohistochemistry. D. SENTINEL NODE # 3 COUNT. - Keratin is negative by Immunohistochemistry. E. SENTINEL NODE # 4 COUNT. - Keratin is negative by Immunohistochemistry. F. SENTINEL NODE # 5 COUNT. - Keratin is negative by Immunohistochemistry. Intraoperative Consultation. A. Sentinel node # 1 count. FS: Negative for carcinoma. B. Suspicious lymph node right breast FS: Negative for carcinoma. C. Sentinel node # 2 count. FS: Negative for carcinoma. D. Sentinel node # 3 count. FF: Negative for carcinoma. E. Sentinel node # 4 count. FS: Negative for carcinoma. F. Sentinel node # 5 count. FS: Negative for carcinoma. Clinical History: Right breast cancer. Operation Performed. Right partial mastectomy with sentinel node biopsy and axillary node dissection. Pre Operative Diagnosis: None provided. Specimen(s) Received: A: Sentinel node # 1 count. FS. B: Suspicious lymph node right breast FS. C: Sentinel node # 2 count. FS. D: Sentinel node # 3 count. FS. E: Sentinel node # 4 count. FS. F: Sentinel node # 5 count. FS. G: Right breast, short stitch superior long lateral. Gross Description: A. Received fresh is one lymph node measuring 0.7 cm in diameter. Specimen was evaluated during frozen section and. submitted in one cassette. B. Received fresh is one tiny lymph node measuring 0.3 cm in greatest dimension. Submitted in toto in one cassette for. frozen section. C. Received fresh is one lymph node measuring 1 cm in greatest dimension. Specimen was evaluated during frozen section. and submitted in toto in one cassette. D. Received fresh is one lymph node measuring 1.2 cm in greatest dimension. Frozen section submitted in one cassette. Rest of adipose tissue measuring 1.5 x 1 x 0.5 cm, submitted in cassette 2. Both specimens submitted in toto in two. cassettes. E. Received fresh is one lymph node, bisected, measuring 0.9 cm in greatest dimension. The specimen was evaluated. during frozen section examination. Submitted in toto in one cassette. F. Received fresh is one lymph node, bisected, measuring 0.3 cm in greatest dimension. Frozen section submitted in one. cassette. Rest of adipose tissue measuring 1 x 0.5 x 0.5 cm, submitted in cassette 2. G. Received in formalin is a 195 grams, right partial mastectomy specimen measuring 11 x 10 x 6 cm. The specimen was. already cut opened when received. A very soft skin ellipse measuring 4.5 x 2 cm is present at the anterior surface. nipple is present An irregular shaped tan white fibrotic mass measuring 2.8x 2.5 x 2.5 cm, is present at the junction of. upper-outer and lower-outer quadrants. The mass is approximately 0.9 cm from the anterior skin margin and 2.5 cm from. the posterior deep inked margin. A separate irregular shaped tan white nodular mass is present measuring 0.3 cm in. greatest dimension, and 0.3 cm from the main tumor mass. Sections are as follows: 1. Deep margin. 2. Tumor with skin. 3. Tumor with anterior lateral and anterior inferior. 4&5. Composite sections of tumor. 6. Tumor. 7. Tumor with small nodule. 8. Upper outer quadrant. 9. Inner outer quadrant. 10. Lower inner quadrant. 11. Additional tumor.

expanded version (tokens=2482) : 
 Histological Classification: 
- Invasive ductal carcinoma, poorly differentiated
- Ductal carcinoma in situ, high grade (DIN 3), with necrosis
- Lobular carcinoma in situ not identified

Subtype:
- LumB

Description of any necrosis:
- Necrosis present in DCIS

Tumor infiltrating lymphocytes:
- Not mentioned

Histological grade:
- Nottingham grade 2 for invasive carcinoma
- Nuclear grade 3 for ductal carcinoma in situ
- Overall grade 3 with a score of 8

Nuclear grade:
- Score 2 for nuclear pleomorphism

Lymphovascular invasion:
- Not identified

Calcification:
- Microcalcifications not identified

Receptor status:
- Estrogen receptor present in 1% of tumor cells
- Progesterone receptor present in 1% of tumor cells
- HER2 negative (score 0)

IHC and other ancillary testing results: 
- ID5 clone used for ER staining
- PgR 636 clone used for PR staining
- A485 clone used for HER2 staining
- H-11 clone used for ECFR staining
- FISH for HER2/neu not performed

Other pertinent information: 
- Six sentinel lymph nodes examined, all negative for malignancy
- Margins uninvolved by invasive carcinoma and DCIS
- Tumor site in upper outer and lower outer quadrants 
- pT2 NO

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2632) : 
 Histological diagnosis of a 2.8cm poorly differentiated, invasive ductal carcinoma of the LumB subtype with papillary features and high-grade necrotic DCIS in partial right breast mastectomy. No tumor infiltrating lymphocytes or calcifications identified. Lymphovascular invasion not present. ER and PR present in 1% of tumor cells, while HER2 is negative by IHC and FISH for HER2/neu not performed. All six sentinel lymph nodes tested negative for malignancy.

